Infliximab, a TNF-α inhibitor, reduces 24-h ambulatory blood pressure in rheumatoid arthritis patients

Infliximab, a TNF-α inhibitor, reduces 24-h ambulatory blood pressure in rheumatoid arthritis patients Journal of Human Hypertension advance online publication, September 5 2013. doi:10.1038/jhh.2013.80 Authors: S Yoshida, T Takeuchi, T Kotani, N Yamamoto, K Hata, K Nagai, T Shoda, S Takai, S Makino & T Hanafusa

http://feeds.nature.com/~r/jhh/rss/aop/~3/OWJ6uknf7jE/jhh.2013.80

Source: Journal of Human Hypertension - September 5, 2013 Category: Cardiology Authors: S YoshidaT TakeuchiT KotaniN YamamotoK HataK NagaiT ShodaS TakaiS MakinoT Hanafusa Tags: blood pressure norepinephrine renin–angiotensin system rheumatoid arthritis tumour necrosis factor Source Type: research